Cardiovascular diseases (CVDs) increasingly burden health systems and patients
worldwide, necessitating the improved awareness of current treatment possibilities and the …

Nanotechnology is envisaged to provide a dynamic approach to treat blocking of the
coronary arteries that occurs due to resistance to the normal blood flow to the heart …

Drug-eluting stents (DES) demonstrated superior efficacy when compared to bare metal
stents and plain-old balloon angioplasty and are nowadays used in almost all percutaneous …

Over the past decade the introduction of drug-eluting stents (DESs) has revolutionised the
treatment of coronary artery disease. However, in recent years concern has arisen over the …

Compared with early bare‐metal stents, drug‐eluting stents (DESs) are more effective in
treating coronary artery diseases, especially in inhibiting restenosis. However, in‐stent …

Despite advances in stent design, expansion techniques and anti-thrombotic agents to
improve pharmacological control of subacute thrombosis (SAT) and to reduce to 2 the …

Compared to bare-metal stents (BMSs), drug-eluting stents (DESs) have been regarded as a
revolutionary change in coronary artery diseases (CADs). Releasing pharmaceutical agents …

Over the past decade, drug-eluting stents (DES) have greatly transformed the field of
interventional cardiology. Generally, three components are included in a DES system: a …

This review aims to provide a glimpse into the future of drug-eluting stents (DES). Since their
arrival in 2002, DES have transformed the practice of interventional cardiology by drastically …

Background: Since its introduction in clinical cardiology, several studies have shown the
superiority of coronary stent implantation as compared to conventional angioplasty …